Sabra Healthcare Reit Stock Today

SBRA Stock  USD 17.26  0.07  0.40%   

Performance

Insignificant

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Sabra Healthcare is trading at 17.26 as of the 21st of March 2025, a 0.4 percent decrease since the beginning of the trading day. The stock's open price was 17.33. Sabra Healthcare has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain
Equity Real Estate Investment Trusts (REITs)
IPO Date
2nd of April 2002
Category
Real Estate
As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 237.91 M outstanding shares of which 20.47 M shares are at this time shorted by private and institutional investors with about 7.06 trading days to cover. More on Sabra Healthcare REIT

Moving against Sabra Stock

  0.37RC Ready Capital CorpPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Sabra Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Chairman, CEO and PresRichard Matros
Business ConcentrationDiversified REITs, Equity Real Estate Investment Trusts (REITs), Real Estate, NASDAQ Composite Total, SP Midcap 400, Real Estate, Diversified REITs, REIT—Healthcare Facilities, Real Estate (View all Sectors)
Average Analyst Recommendation
Debt Levels
Sabra Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sabra Healthcare's financial leverage. It provides some insight into what part of Sabra Healthcare's total assets is financed by creditors.
Liquidity
Sabra Healthcare REIT currently holds 1.76 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.

Change In Cash

20.6 Million
Sabra Healthcare REIT (SBRA) is traded on NASDAQ Exchange in USA. It is located in 1781 Flight Way, Tustin, CA, United States, 92782-0539 and employs 50 people. Sabra Healthcare is listed under Diversified REITs category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.12 B. Sabra Healthcare REIT conducts business under Diversified REITs sector and is part of Real Estate industry. The entity has 237.91 M outstanding shares of which 20.47 M shares are at this time shorted by private and institutional investors with about 7.06 trading days to cover. Sabra Healthcare REIT currently holds about 49.05 M in cash with 310.54 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.21.
Check Sabra Healthcare Probability Of Bankruptcy
Ownership Allocation
The majority of Sabra Healthcare REIT outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sabra Healthcare to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sabra Healthcare REIT. Please pay attention to any change in the institutional holdings of Sabra Healthcare REIT as this could imply that something significant has changed or is about to change at the company.
Check Sabra Ownership Details

Sabra Stock Institutional Holders

InstituionRecorded OnShares
Ameriprise Financial Inc2024-12-31
912.2 K
View Sabra Healthcare Diagnostics

Sabra Healthcare Historical Income Statement

At present, Sabra Healthcare's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 500 M, whereas Depreciation And Amortization is forecasted to decline to about 121.5 M. View More Fundamentals

Sabra Stock Against Markets

Sabra Healthcare Corporate Management

Peter NylandExecutive ManagementProfile
Michael CostaCFO VPProfile
Eliza GozarSenior InvestmentsProfile
Kara PappandurosSenior ManagementProfile
Darrin SmithExecutive InvestmentsProfile
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.827
Dividend Share
1.2
Earnings Share
0.54
Revenue Per Share
3.009
Quarterly Revenue Growth
0.125
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.